초록접수 현황

21F-004 구연 발표

Routine compression stocking with or without additional target vein compression after ultrasonography guided foam sclerotherapy: A prospective, intrapersonal, randomized controlled trial.
Kilsoo Yie, Eun Hee Jeong, A Rom Shin, Eun Jung Hwang, Seong Do Kim
Jeju Soo CardioVascular Clinic (JSCVC), Jeju, Republic of Korea

Purpose : The efficacy of additional target vein compression to the selective targeted truncal veins has not been explored. This study analyses the efficacy of additional compression.

Methods : From 2020 to 2021, 42 patients of CEAP class 0 or 1 who underwent bilateral endovenous surgery for great saphenous vein (GSV) reflux were enrolled. All 84 limbs received endovenous surgery to the thigh area and then 0.75% ultrasonography guided foam sclerotherapies (UGFS) were conducted to below the knee GSV (BKGSV). Routine class II compression stocking for postoperative 24-hours was applied to one limb (RC group), and compression stocking with additional target vein area compression (AC group) was performed to another limb after intrapersonal limb randomization. The primary outcome was the closure range of BKGSV, and secondary outcomes were VAS pain score, the required number of additional UGFS, pigmentation scores.

Results : Thirty-seven patients (88.1%) were female, and mean ages were 47.3 (24-69 yrs). Endovenous laser treatment (n=44), radiofrequency ablation (n=14), and endovenous cyanoacrylate procedure (n=26) were performed for thigh GSV procedure. Primary outcome was similar in both group (84.7±19.4% vs 80.8±19.4%, p=0.1406 at 1 day; 85.6±17.3% vs 88.8 ±13.6%, p=0.2516 at 1 week; 91.2±11.0% vs 90.5±10.2%, p=0.8194 at 1 month). Secondary outcomes of VAS pain score, numbers of additional UGFS, and pigmentation were similar.

Conclusion : Compared to routine class II compression stocking for 24 hours, additional target vein selective compression failed to show clinical advantages in terms of closure ranges, VAS pain score, required numbers of additional UGFS, and pigmentation in the BKGSV.


책임저자: Kilsoo Yie
Jeju Soo CardioVascular Clinic (JSCVC), Jeju, Republic of Korea
발표자: Eun Hee Jeong, E-mail : eh_0421@naver.com

목 록